期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | European Journal of Oncology Nursing LetPub Score 5.3
50 ratings
Rate
Reputation 6.4 Influence 3.9 Speed 7.0 | ||||||||||||||||
期刊簡稱 | EUR J ONCOL NURS | ||||||||||||||||
ISSN | 1462-3889 | ||||||||||||||||
E-ISSN | 1532-2122 | ||||||||||||||||
h-index | 49 | ||||||||||||||||
CiteScore |
| ||||||||||||||||
自引率 (2023-2024) | 7.40%自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | https://www.journals.elsevier.com/european-journal-of-oncology-nursing | ||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/YEJON | ||||||||||||||||
開放訪問 | No | ||||||||||||||||
出版商 | Churchill Livingstone | ||||||||||||||||
主題領域 | 医学 | ||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||
發行頻率 | 隔月刊行 | ||||||||||||||||
創刊年 | 1998 | ||||||||||||||||
每年文章數 | 185每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 21.81% | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded Social Science Citation Index | ||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1462-3889%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Slow, 6-12 Week(s) 來自Elsevier的數據: Average 10.8 Week(s) | ||||||||||||||||
競爭力 * | 來自作者的數據: Moderate 來自Elsevier的數據: 26% | ||||||||||||||||
在線文章發布時間 | 來自Elsevier的數據: Average 12.4 Week(s) | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 下一頁 末頁 (頁 | |
[European Journal of Oncology Nursing] 的評論 | 撰寫評論 |
作者: 觅枫小公主 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-22 23:33:08 評論於 How long does it take to receive feedback after a minor repair?(0) 讚! | 觅枫小公主 |
作者: 觅枫小公主 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-09 09:18:08 評論於 Please translate the following passage into English and Japanese, and title them ":" and ":"(0) 讚! | 觅枫小公主 |
作者: 觅枫小公主 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-03 14:47:00 評論於 Why has it been one month with my editor? I don't dare to rush(0) 讚! | 觅枫小公主 |
作者: 小新真吖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-09-13 10:47:11 評論於 Very efficient within one week online(0) 讚! | 小新真吖 |
作者: 小新真吖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-09-07 23:37:39 評論於 Review speed: 2.0 | Submission hit rate: 75.0 Emphasized research direction: Nutrition Nursing experience sharing: 5.26 submission, 5.29 with editor, 6.4 under review, 7.22 major revision, 8.16 revised submission, 8.17 with editor, 9.8 accepted. Reviewers are very friendly, raised detailed questions, requiring language polishing, overall feeling is okay. Medium speed(0) 讚! | 小新真吖 |
作者: 金蛇恬美 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-04-07 14:33:15 評論於 Research focus: Cancer; Nursing experience sharing: This journal does not exclude cross-sectional studies(0) 讚! | 金蛇恬美 |
作者: 金蛇恬美 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-04-07 12:47:00 評論於 You can select the needs of ESTEE LAUDER, it is very good, more than 2,000 RMB(0) 讚! | 金蛇恬美 |
作者: 金蛇恬美 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-04-07 11:46:17 評論於 Review speed: 2.0 | Submission success rate: 75.0 Research focus: Cancer Nursing experience sharing: 22nd November 2022 Submit 23rd November 2022 Under review 23rd January 2023 Major revision 1st February 2023 Revision submitted 10th March 2023 Accepted The whole process took a little over three months and went smoothly. Language polishing is needed, and page charges are optional. I choose not to pay for open access(0) 讚! | 金蛇恬美 |
作者: 为贪玩还债 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-09 17:36:09 評論於 Hello, may I ask how long does it take with the editor? Approximately how long does it take under review?(0) 讚! | 为贪玩还债 |
作者: 金蛇恬美 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-25 08:42:09 評論於 Research Focus: Cancer Experience Sharing: Submitted on November 22, 2022, Major Revision due on January 22, 2023(0) 讚! | 金蛇恬美 |
作者: 削月芮欢 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-08-01 10:07:09 評論於 Is this magazine free?(0) 讚! | 削月芮欢 |
作者: 北风幻雪 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-06-09 15:59:00 評論於 Brother, is it normal for this magazine to still be in the initial review after nearly a month?(0) 讚! | 北风幻雪 |
作者: 中原春柳 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-04-25 20:43:25 評論於 What type of article did you submit?(0) 讚! | 中原春柳 |
作者: 阿糖 領域: 医学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2022-01-23 11:01:01 評論於 The overall speed is quite fast. Two reviewers gave their opinions. After making the modifications, it was accepted in less than two months. Within 11 days of acceptance, there was already an online version. The overall feeling is quite good.(2) 讚! | 阿糖 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 21:31:34 評論於 Highlight the innovation of your research, showing distinctive features different from others. The difference in size is another issue, but the important thing is to have a difference. As long as there is a difference, it is innovation(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 11:42:06 評論於 Given the diversity and complexity of biology, it is perfectly acceptable for different outcomes to emerge and be published because scientific research itself allows and encourages questioning, supplementing, and improving on previous knowledge, or even overturning it. When writing a paper, two main strategies should be emphasized: accurately describing materials and methods, especially any discrepancies from others, in detail; in the discussion section, do not avoid contradictions, compare similarities and differences with previous researchers, and attempt to provide reasonable and effective explanations(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 破戒阳平 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 22:28:47 評論於 How to highlight the innovation of an article in a discussion?(0) 讚! | 破戒阳平 |
作者: 魂魄彦露 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 08:57:20 評論於 How to handle disagreement between my discussion and previously published articles?(0) 讚! | 魂魄彦露 |
作者: 苍风海荣 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-09-20 09:30:21 評論於 May I ask how much is the layout fee and is there an additional charge for color images? Thank you(0) 讚! | 苍风海荣 |
作者: Leopold Tennyson 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-08-16 17:35:09 評論於 This magazine is very good. As long as the articles are written clearly and innovatively, feedback will be given within two months of submission, and if revisions are made within one week, they will be accepted and published online in another week. I have submitted three times and all have been accepted; today I am preparing to submit the fourth(0) 讚! | Leopold Tennyson |
作者: 黯然恬悦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-06-16 23:36:54 評論於 Which company are you looking for? drhuang 2016-02-02 post:: Acceptance rate: about 75% Review time: about 6 months Pass one, review for more than 3 months, it is best to have the company improve the language before submitting it, and the hit rate will be higher. online is very fast(0) 讚! | 黯然恬悦 |
作者: 风啸之槐 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-09-23 10:03:07 評論於 Which magazine?(0) 讚! | 风啸之槐 |
作者: 小承悦吖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-06-14 19:08:58 評論於 I have submitted my paper to another geriatric medicine journal. It will be accepted after major or minor revisions. if1.971(0) 讚! | 小承悦吖 |
作者: 岭南思丝 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-02-02 18:08:42 評論於 Review speed: 6.0 | Submission hit rate: 75.0 Experience sharing: After having one paper accepted, it took over 3 months for the review process. It is recommended to have the language polished by a company before submitting, as it can increase the hit rate. The online submission process is quick(0) 讚! | 岭南思丝 |
作者: 小承悦吖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-07-30 14:52:47 評論於 The response was very prompt, with high language requirements and a somewhat "arrogant" attitude. It doesn't feel good, and I will never submit again. There are hardly any articles from mainland China, only a few from Hong Kong. Upon checking, the authors' affiliations turned out to be collaborations between editors and the University of Hong Kong(0) 讚! | 小承悦吖 |
首頁 上一頁 1 2 下一頁 末頁 (頁 |
Contact us